- Home
- Your Messages
-
Smartest Doc
Test your clinical knowledge against other physicians in the USA by taking our FREE daily quiz!
We invite you to take the "Diabetes Expert Quiz"
Current Top Players:
1) Dr. Marvin Den
2) Dr. George Bahadue
3) Dr. Wendy Lee
>> Live LeaderboardNew! PHYSICIAN REVIEW
Assess your general knowledge at the topic level with your personalized scorecard.
Thousands of multiple-choice questions pinpoint your areas of expertise and prep you for exams.
- Physician Jobs (1154)
- More
- Other Specialty
Endocrinology - Endocrine Oncology News & Articles
MDLinx Endocrinology Overview: Our medical editors have ranked and organized papers in the top peer-reviewed clinical journals by topic including diabetes types 1 and 2, thyroid and glandular diseases, obesity and dyslipidemia. In a matter of minutes, you and all the members of your patient care team can stay current on the literature as it is published.
Also on this page: MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD, and clinical pearls from The Smartest Diabetes Expert as well as endocrinology topics in The Smartest Internist, The Smartest Family Physician, and The Smartest Pediatrician daily quiz challenges.
Your Unread Messages in Endocrinology
See All >> Messages include industry-sponsored communications and special communications from MDLinx-
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Diabetes is not a risk factor for HCC -
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage -
Smartest Doc Challenge
MDLinx
Thyroid Clinical Pearls -
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools -
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
Articles
Latest (1) Full Text Articles (117) Focus on Reproduction401 Biomarkers of Parathyroid Carcinoma Endocrine Pathology, September 25, 2012
402 Preoperative serum thyroglobulin as a useful predictive marker to differentiate follicular thyroid cancer from benign nodules in indeterminate nodules Full Text Journal of Korean Medical Science, September 21, 2012
403 Cancer With Diabetes: Prevalence, Metabolic Control, and Survival in an Academic Oncology Practice Endocrine Practice, September 20, 2012 Clinical Article
404 CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort Cellular Oncology, September 20, 2012
405 Prognostic Factors Determining Survival in Patients with Node Positive Differentiated Thyroid Cancer: a retrospective cross-sectional study Clinical Otolaryngology, September 19, 2012
406 Phase I study of pasireotide (SOM 230) and everolimus (RAD001) in advanced neuroendocrine tumors Endocrine-Related Cancer, September 18, 2012
407 Fluorodeoxyglucose-positron emission tomography scan-positive recurrent papillary thyroid cancer and the prognosis and implications for surgical management World Journal of Surgical Oncology, September 18, 2012
408 Aromatase cytochrome P450 enzyme expression in prolactinomas and its relationship to tumor behavior Pituitary, September 18, 2012
409 A molecular computational model improves the preoperative diagnosis of thyroid nodules Full Text BMC Cancer, September 12, 2012
410 Short-term hypothyroidism in thyroid cancer patients and cognitive-motor performance relevant for driving Psychoneuroendocrinology, September 11, 2012
411 Mortality and morbidity in adult craniopharyngioma Pituitary, September 11, 2012
412 Ultrasound Findings of Papillary Thyroid Microcarcinoma: A Review of 113 Consecutive Cases with Histopathologic Correlation Ultrasound in Medicine and Biology, September 7, 2012
413 Obesity, type 2 diabetes, and cancer: the insulin and IGF connection Endocrine-Related Cancer, September 6, 2012
414 Insulin resistance and cancer: epidemiological evidence Endocrine-Related Cancer, September 6, 2012
415
Gene expression profiles of phaeochromocytomas with
416 Carcinoid tumours: predicting the location of the primary neoplasm based on the sites of metastases European Radiology, September 5, 2012
417 Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials Diabetologia - Clinical and Experimental Diabetes and Metabolism, August 29, 2012 Clinical Article
418 A subset of papillary thyroid carcinomas contain KRAS mutant subpopulations at levels above normal thyroid Molecular Carcinogenesis, August 29, 2012
419 Implantation at Sternocleidomastoid and Chest Wall After Endoscopic Thyroid Carcinoma Surgery Surgical Laparoscopy, Endoscopy & Percutaneous Techniques, August 28, 2012
420 Alveolar soft part sarcoma of the paranasal sinuses masquerading as a giant invasive pituitary adenoma Annals of Diagnostic Pathology, August 28, 2012
Clinical Pearls in Endocrinology
- Pioglitazone can reduce the risk of conversion of impaired glucose tolerance to type 2 diabetes mellitus by 72%, but it was also associated with significant weight gain and edema
- The most commonly reported adverse event associated with Janumet in the treatment of type 2 diabetes is diarrhea, followed by upper respiratory tract infection and headache
- Maturity-onset diabetes of the young (MODY)3 can be treated with sulfonylureas with excellent results for decades
Highlights in Endocrinology
Regulatory protein identified in T1DM
As published in Pancreas, researchers at the Bowman Gray School of Medicine have identified a protein (islet homeostasis protein [IHoP]) which appears to control blood glucose levels by regulating the balance between insulin and glucagon. IHoP is released from glucagon-producing cells in the islets. In both humans and animals, high levels of IHoP exist in the euglycemic state, while T1DM is associated with an absence of IHoP. The authors suggest that IHoP may serve as a target in the treatment of T1DM.
Read the article summaryStatins increase risk of DM in postmenopausal women
As reported in the Archives of Internal Medicine, researchers at the Mayo Clinic have shown an association between statin use and diabetes mellitus in postmenopausal women. The study involved 161,808 postmenopausal women (age range, 50-79 years) who were enrolled at 40 centers between 1993 and 1998 as part of the Women’s Health Initiative. Of the study cohort, data was available for 153,840 women without diabetes at baseline, 7.04% of whom used statins. There were 10,242 incident cases of diabetes in statin users (HR = 1.71) during 1,004,466 person-years of follow-up
Read the article summaryDetermining the basal insulin dosage in T2DM
Anthropometric, laboratory, and clinical findings were evaluated in 681 patients with type 2 diabetes mellitus to determine the factors with the greatest influence on determining the basal insulin dosage for a target glucose level < 120 mg/dL. The authors reported that waist circumference, the duration of insulin treatment, lipid-lowering medications, use of insulin sensitizers, the HbA1c, fasting plasma glucose, HDL-C, and triglycerides levels, and severe NAFLD were most significant.
Read the article summaryMost Popular Endocrinology Articles
Last month's top read Top Articles of 2012Indexed Journals in Endocrinology: Endocrinology, Journal of Endocrinology, Clinical Endocrinology, Diabetes more
Other Topics in Endocrinology
Register now to view all the MDLinx contents (FREE)!
- Stay current on the latest literature, research and clinical news
- Get special communications and offers from MDLinx and our sponsors
- Receive invitations to paid market research
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close